Document:

Separation Agreement

 Exhibit 10.1 
 March 14, 2006 
 Mr. Michael W. Towe 
 Dear Mike: 
 This letter agreement (“Agreement”) confirms the agreements and understandings between you and Roper Industries, Inc. (the “Company”)
regarding (1) your separation from service with the Company, (2) the benefits to which you are entitled upon separation, and (3) the additional consideration the Company is offering to you in exchange for a complete release of any and
all claims against the Company and any Affiliate, as set forth below. 
 Separation Date 
 The parties to this Agreement acknowledge that you have indicated your desire to pursue other interests and that the Company has agreed to your
separation from service from the Company. To effect such separation, the parties have agreed that your employment with the Company will end on the terms and conditions described in this Agreement, including the release outlined below, and that the
separation will be effective on the date first written above (hereafter the “Separation Date”), provided that the release described below will be effective from the date of your signature below if that date is later. 
 Separation Benefits 
 By accepting the terms
of this Agreement, you will become entitled to receive the following compensation and benefits from the Company: 
 Health and Welfare
Benefits – If you were participating in medical, dental, and/or vision coverage for yourself and any eligible dependents, all active coverage will end as of the Separation Date. You will receive a packet regarding continuation of benefits under
COBRA (Consolidated Omnibus Benefits Reconciliation Act), and you and any eligible dependents may elect to continue coverage for up to an additional eighteen (18) months, provided you timely enroll for coverage. The Company will pay the cost of
the first twelve (12) months of COBRA coverage for you. In addition, the Company will continue any other healthcare reimbursement benefit(s) for yourself in which you were participating on the Separation Date for the first (12) months
following the Separation Date. All other health and welfare benefits end as of the Separation Date. 
 Initial Award of Restricted Stock
– Because we have mutually agreed to your separation from the Company, the 15,000 restricted shares awarded to you at the time of hire (now 30,000, after giving effect to the recent stock split) will vest on the eighth day immediately following
the Separation Date. 

 Options – The deadline to exercise any fully vested options that you hold on the Separation Date
will be extended to sixty (60) days after the Separation Date. 
 Severance – You will receive severance pay at your current base
salary level through December 31, 2006. You will also receive an additional severance payment of $15,000 within 15 days after the Separation Date. 
 Incentive – For the 2005 plan year, the Company agrees to waive the requirement of continued employment for incentive eligibility and agrees to pay to you a $100,000 incentive payment for the 2005 plan year,
which will be paid to you within 15 days after the Separation Date. 
 Perquisites – All perquisites, such as your Executive Financial
Planning Allowance and your Company car, terminate as of the Separation Date. 
 Return of company property – You may cooperate with the
Company to arrange a convenient time and place to return the Company car or you must surrender it immediately if requested to do so by the Company. You must immediately return to the attention of Mr. David Liner, General Counsel, Roper
Industries, Inc. 2160 Satellite Blvd, Suite 200, Duluth, GA 30097, all other Company property in your possession, including but not limited to computers, credit cards, documents and records of the Company or any Affiliate, in whatever medium and of
whatever kind or type. As additional consideration for the release below, after the Company has had an opportunity to remove any Company data from the Company computer that is currently assigned to you, the Company will transfer ownership of that
computer to you on an as-is, where-is basis. After the Separation Date you should no longer have files or documents containing confidential information of the Company in your possession, however, to the extent any such information remains in your
possession or memory, you agree to continue to protect that information and refrain from using or disclosing that information. 
 Release

 The Company’s decision to offer additional consideration in exchange for a release of claims shall not be construed as an admission
by the Company of (i) any liability whatsoever, (ii) any violation of any of your rights or those of any person, or (iii) any violation of any order, law, statute, duty, or contract. The Company specifically disclaims any liability to
you or to any other person for any alleged violation of any rights possessed by you or any other person, or for any alleged violation of any order, law, statute, duty, or contract on the part of the Company, its employees or agents or related
companies or their employees or agents. 
 You acknowledge that the consideration being paid to you under the terms of this Agreement exceeds
the amount, if any, to which you are otherwise entitled. 

 The release and discharge of claims contained herein applies to (i) Roper Industries, Inc.,
(ii) to each and all of its Affiliates1, (iii) to each of their past, present, and future officers,
agents, directors, supervisors, employees, representatives, and their successors and assigns, whether or not acting in the course and scope of employment, and (iv) to all persons acting by, through, under, or in concert with any of the
foregoing persons or entities (all collectively the “Company” for purposes of this release). 
 The claims subject to this release
include, without limitation, any and all claims related or in any manner incidental to your employment with the Company or the termination of that employment relationship. The parties understand the word “claims” to be as broad as legally
possible and to include all actions, claims, and grievances, whether actual or potential, known or unknown, and specifically but not exclusively all claims based on any act, omission or statement to or about you (express or implied, written or oral)
occurring at any time before you sign this Agreement, whether arising out of your employment with the Company or the termination of your employment or otherwise. All such claims (including related attorneys’ fees and costs) are forever barred
by this Agreement, without regard to whether those claims are based on an alleged violation of any federal, state, municipal or other law, contract, or common-law duty; any alleged unlawful act; and any other claim or cause of action, regardless of
the forum in which it might be brought and regardless of whether it is based upon domestic or foreign laws, including without limitation, the laws of the United States of America (and any jurisdiction within). This release applies to any claims
brought by any person or agency on behalf of you or any class action pursuant to which you may have any right or benefit. 
 This release
includes all claims, whether known or unknown, that are related or in any manner incidental to your employment with the Company or the termination of that employment relationship, up to the date you sign this Agreement. Some of the types of claims,
that you are releasing, although there also may be others not listed here, are claims related to: 
  

	 	a.	Discrimination and harassment on the basis of sex, race, color, national origin, religion, disability or veteran status; 

  

	 	b.	Breach of contract, wrongful discharge (including retaliatory discharge) or any other possible restrictions on the Company’s ability to terminate its employees at will,
including but not limited to (i) violation of public policy, (ii) breach of any express or implied contract, including but not limited to any claims under your offer letter dated October 20, 2004, and (iii) breach of any duty of
good faith and fair dealing; 

  

	1	For purposes of this Agreement, an “Affiliate” includes any firm, company, business entity or other organization: (a) which is directly or indirectly
controlled by the Company, or (b) which directly or indirectly controls the Company, (c) which is directly or indirectly controlled by a third party who also directly or indirectly controls the Company, (d) of which the Company or any
Affiliate is a partner, or (e) of which the Company or any Affiliate owns or has a beneficial interest (whether directly or indirectly) in 20% or more of the issued share capital or 20% or more of the capital assets. 

	 	c.	Discrimination on the basis of age, including claims under the Age Discrimination in Employment Act (the “ADEA”), which is located at 29 United States Code,
Sections 621 through 634, the Older Workers’ Benefits Protection Act (the “OWBPA”), and any applicable state or local law prohibiting age discrimination; 

  

	 	d.	Negligence, defamation, invasion of privacy, fraud, misrepresentation, denial of leave or other terms and conditions of employment, or infliction of emotional or mental distress;
and 

  

	 	e.	Breach of any oral or written contract. 

 If you so
choose, you may take up to twenty-one (21) days to consider whether or not to sign this Agreement. You acknowledge and represent (i) that you have not been asked by the Company to shorten the time-period for consideration of whether to
sign this Agreement, (ii) that the Company has not threatened to withdraw or alter the benefits due prior to the expiration of the 21-day period, and (iii) that the Company has not provided different terms to you in exchange for your
agreement to sign the Agreement prior to the expiration of the 21-day consideration period. You agree that any changes to the terms this Agreement that result from negotiations between you and the Company, whether material or immaterial, will not
restart the running of the 21-day consideration period. 
 You understand that you have a seven-day period after signing this Agreement in
which to revoke or rescind this Agreement by informing Mr. David Liner, General Counsel, Roper Industries, Inc. 2160 Satellite Blvd, Suite 200, Duluth, GA 30097, in writing of your decision to revoke or rescind, and this Agreement will not
become effective until the seven-day period has expired. This Agreement will become effective upon the expiration of the seven-day period following the date upon which you signed the Agreement, provided that you have also returned it to the Company.
No consideration will be paid for the release until at least the eighth day after you sign this Agreement. 
 You promise never to file a
lawsuit asserting any claim that is released by you and further promise not to accept any recoveries or benefits which may be obtained on your behalf by any other person or agency or in any class action and do hereby assign any such recovery or
benefit to the Company. Notwithstanding the foregoing, the release contained herein shall not apply to (i) any rights that you may have under the Company’s retirement plans including the 401(k) plan, (ii) any rights you may have under
this Agreement, (iii) your right under applicable law (i.e., COBRA) to continued medical insurance coverage at your expense, (iv) your statutory right to file a charge with the U.S. Equal Employment Opportunity Commission
(“EEOC”), to participate in an EEOC investigation or proceeding, and to challenge the validity of the release, consistent with the requirements of 29 U.S.C. § 626 (f)(4), the ADEA, and the OWBPA, and (v) any claims that may arise
after the date this release is signed. 
 In connection with this release, you acknowledge and agree that: 
 (1) You have carefully read and fully understand all the provisions of the Agreement, and you acknowledge that the Agreement is written in a manner that
you understand. 

 (2) You declare that your agreement to all of the terms set forth in this Agreement is knowing and is
voluntary. 
 (3) You knowingly and voluntarily intend to be legally bound by the terms of this Agreement. 
 (4) You acknowledge that the Company is hereby advising you in writing to consult with an attorney of your choice prior to executing this
Agreement. 
 (5) If you choose to do so, you may waive the remainder of the 21-day consideration period by signing and returning this
Agreement to the Company before the end of the period. 
 You represent and acknowledge that in executing this Agreement you do not rely and
have not relied upon any representation or statement made by the Company or by any of the Company’s agents, attorneys, or representatives with regard to the subject matter, basis, or effect of this Agreement, other than those specifically
stated in this Agreement. 
 The release set forth in this Agreement shall be binding upon you and your heirs, administrators,
representatives, executors, successors, and assigns, and shall inure to the benefit of the Company as defined above. Provided, however, you expressly warrant that you have not assigned, transferred or sold to any person or entity any rights, causes
of action, or claims released in this Agreement. 
 Miscellaneous 
 You agree that you will not criticize or disparage the Company or any of its employees, officers or directors in any public communication, whether orally
or in writing. Likewise, the Company agrees that it will not criticize or disparage you in any public communication, whether orally or in writing. In addition, if the Company is requested to provide information regarding your separation from service
with the Company, the Company will confirm that your separation was mutually agreed upon so that you could pursue other interests. 
 This
Agreement constitutes the entire agreement and understanding between the parties concerning your employment with the Company and the termination thereof and supersedes all prior negotiations and agreements, whether oral or written, concerning the
subject matters addressed herein. This Agreement is intended by the parties to be a fully integrated agreement. 

 By their signatures below, the parties indicate their acceptance to the terms of this Agreement.

  

							
	ROPER INDUSTRIES, INC.	  		 	
				
	By:	 	 /s/ Brian D. Jellison
	  		 	 /s/ Michael W. Towe

		 	Brian D. Jellison	  		 	Michael W. Towe
		 	Chairman, President & CEO	  		 	
				
		 		  		 	Date: March 14, 2006Third Amendment to Development Agreement

 Exhibit 10.19 
 THIRD AMENDMENT TO DEVELOPMENT AGREEMENT 
 This THIRD AMENDMENT TO DEVELOPMENT AGREEMENT
(“Amendment”) is made as of February 2, 2006, by and between BOSTON SCIENTIFIC CORPORATION (“BSC”), a Delaware corporation, and CORAUTUS GENETICS INC. (the “Company”), a Delaware
corporation (each a “Party,” and collectively, the “Parties”). 
 WHEREAS, pursuant to the Investment
Agreement, dated July 30, 2003, between BSC and Company (the “Investment Agreement”), BSC and Company agreed, subject to the conditions set forth therein, to enter into a Loan Agreement, an Investor Rights Agreement, a
Development Agreement (as amended, the “Development Agreement”), a Distribution Agreement and a Patent Sublicense Agreement; 
 WHEREAS, pursuant to such agreements, the Parties agreed to cooperate to develop products that use VEGF-2 for the treatment of diseases of the heart or peripheral vascular system; 
 WHEREAS, the Development Agreement requires the Company to use commercially reasonable efforts to complete Clinical Development of the Final
Product in accordance with an established schedule set forth in Section 2.03 of the Development Agreement; 
 WHEREAS, the
Parties previously have amended the Development Agreement to modify certain of the dates set forth in Section 2.03 of the Development Agreement in the form of that certain First Amendment to Development Agreement dated as of July 22, 2004
and that Second Amendment to Development Agreement dated as of June 27, 2005; 
 WHEREAS, the Parties have agreed to modify
further certain of the dates in the schedule set forth in Section 2.03 of the Development Agreement; and 
 WHEREAS, capitalized
terms that are not defined in this Agreement shall have the meanings assigned to such terms in the Development Agreement. 
 NOW,
THEREFORE, in consideration of the premises and the mutual representations, agreements and covenants set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties
desire to amend the Development Agreement as follows: 
  

	 	1.	Section 2.03 (b). Section 2.03 (b) of the Development Agreement is hereby deleted in its entirety and replaced with the following: 

  

	 	“(b)	**; and” 

  

	 	2.	All provisions of the Development Agreement, except to the extent specifically amended as provided above, are hereby in all respects ratified and confirmed.

  

	 	3.	This Amendment may be signed in one or more counterparts, which when taken together shall constitute one and the same Amendment. 

  

	**	Confidential Treatment Requested 

 IN WITNESS WHEREOF, the Parties hereto have caused this Amendment to be executed by their
respective officers thereunto duly authorized, as of the date first above written. 
  

			
	CORAUTUS GENETICS INC.
		
	By:	 	/s/ Richard E. Otto
		 	 
		 	 Richard E. Otto
 President and Chief Executive
Officer

	
	BOSTON SCIENTIFIC CORPORATION
		
	By:	 	/s/ Lawrence C. Best
		 	 
		 	 Lawrence C. Best
 Executive Vice President and

Chief Financial Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00100-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00100-of-00352.parquet"}]]